NATA MATTHEWS: Open Payments
NPI 1346724887 · FORT SMITH, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,859 in 157 payments from 15 companies in 2025. Trend: 2023 $2,003 · 2024 $2,434 · 2025 $2,859
Food & beverage: $2,859
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 37 | $623 |
| AstraZeneca Pharmaceuticals LP | 17 | $509 |
| PFIZER INC. | 34 | $299 |
| Bayer Healthcare Pharmaceuticals Inc. | 10 | $288 |
| Novo Nordisk Inc | 14 | $234 |
| Amgen Inc. | 12 | $177 |
| Lilly USA, LLC | 13 | $157 |
| SANOFI-AVENTIS U.S. LLC | 3 | $152 |
| Stryker Corporation | 1 | $121 |
| Otsuka America Pharmaceutical, Inc. | 5 | $114 |
Products named: BREZTRI, Kerendia, VRAYLAR, NURTEC ODT, QULIPTA, TZIELD, UBRELVY, MOUNJARO.
Industry payments across AR — which companies pay providers there.
